LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
121,215,452
Share change
-790,805
Total reported value
$711,536,085
Put/Call ratio
59%
Price per share
$5.87
Number of holders
104
Value change
+$170,291
Number of buys
56
Number of sells
47

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q1 2021

As of 31 Mar 2021, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,215,452 shares. The largest 10 holders included Artal Group S.A., FMR LLC, BVF INC/IL, Ulys, L.L.C., VANGUARD GROUP INC, BlackRock Inc., D. E. Shaw & Co., Inc., NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 104 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.